These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7146855)

  • 21. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Development of malignant uroepithelial neoplasms in the upper urinary tracts in nephropathies caused by analgesic abuse: clinical study based on 16 cases].
    Lornoy W; Morelle V; Becaus I; Fonteyne E
    J Urol Nephrol (Paris); 1979 Sep; 85(9):589-92. PubMed ID: 522204
    [No Abstract]   [Full Text] [Related]  

  • 23. [Analgesic-induced nephropathies].
    Dubach UC
    Ther Umsch; 1982 May; 39(5):351-9. PubMed ID: 7101215
    [No Abstract]   [Full Text] [Related]  

  • 24. NTP Toxicology and Carcinogenesis Studies of 3,4-Dihydrocoumarin (CAS No. 119-84-6) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Sep; 423():1-336. PubMed ID: 12616288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology of analgesic nephropathy in Belgium.
    Vanherweghem JL; Even-Adin D
    Clin Nephrol; 1982 Mar; 17(3):129-33. PubMed ID: 7067174
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-phenacetin analgesics and analgesic nephropathy: clinical assessment of high users from a case-control study.
    Michielsen P; Heinemann L; Mihatsch M; Schnülle P; Graf H; Koch KM
    Nephrol Dial Transplant; 2009 Apr; 24(4):1253-9. PubMed ID: 19037086
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical course of chronic interstitial nephritis due to phenacetin after having stopped the abuse of the analgesic].
    Lameire N; Ringoir S; De Broe M; Daneels R; Lornoy W
    J Urol Nephrol (Paris); 1970 Dec; 76(12):993-7. PubMed ID: 5511436
    [No Abstract]   [Full Text] [Related]  

  • 28. NTP Toxicology and Carcinogenesis Studies of 4,4'-Thiobis(6- t -butyl- m -cresol) (CAS No. 96-69-5) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1994 Dec; 435():1-288. PubMed ID: 12595928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analgesic nephropathy: etiology, clinical syndrome, and clinicopathologic correlations in Australia.
    Nanra RS; Stuart-Taylor J; de Leon AH; White KH
    Kidney Int; 1978 Jan; 13(1):79-92. PubMed ID: 362034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Chronic headache and abuse of phenacetin (author's transl)].
    Haschek H; Porpáczy P; Schmidt W
    MMW Munch Med Wochenschr; 1975 Dec; 117(49):1959-60. PubMed ID: 813132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epidemiological study of analgesic intake and its relationship to urinary tract disorders in Switzerland.
    Dubach UC; Levy PS; Minder F
    Helv Med Acta; 1968 Nov; 34(4):297-312. PubMed ID: 5704615
    [No Abstract]   [Full Text] [Related]  

  • 32. [Phenacetin abuse IV. Are cytological urine studies successful and usable in the prevention of tumors in phenacetin abusers?].
    Dalquen P; Fasel J; Mihatsch MJ; Rist M; Rutishauser G
    Schweiz Med Wochenschr; 1980 Feb; 110(8):302-6. PubMed ID: 7367850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of diagnostic criteria for analgesic nephropathy in patients with end-stage renal failure: results of the ANNE study. Analgesic Nephropathy Network of Europe.
    Elseviers MM; Waller I; Nenoy D; Levora J; Matousovic K; Tanquerel T; Pommer W; Schwarz A; Keller E; Thieler H
    Nephrol Dial Transplant; 1995; 10(6):808-14. PubMed ID: 7566608
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Disease course observation in patients with kidney diseases following abuse of analgesics].
    Nitzsche T; Bock KD
    Dtsch Med Wochenschr; 1970 Apr; 95(17):927-34. PubMed ID: 5439550
    [No Abstract]   [Full Text] [Related]  

  • 35. NTP Toxicology and Carcinogenesis Studies of Oxazepam (CAS No. 604-75-1) in Swiss-Webster and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1993 Aug; 443():1-321. PubMed ID: 12595920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analgesic nephropathy: an underestimated cause of end-stage renal disease.
    Drukker W; Schwarz A; Vanherweghem JL
    Int J Artif Organs; 1986 Jul; 9(4):219-46. PubMed ID: 3536758
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anemia in chronic pyelonephritis and in renal failure of analgesic abusers. With special reference to signs of microangiopathic hemolytic anemia.
    Forsström J
    Acta Med Scand Suppl; 1968; 487():1-63. PubMed ID: 5250509
    [No Abstract]   [Full Text] [Related]  

  • 38. The morphologic diagnosis of analgesic (phenacetin) abuse.
    Mihatsch MJ; Torhorst J; Steinmann E; Hofer H; Stickelberger M; Bianchi L; Berneis K; Zollinger HU
    Pathol Res Pract; 1979 Apr; 164(1):68-79. PubMed ID: 461222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenacetin abuse and malignant tumors. An autopsy study covering 25 years (1953-1977).
    Mihatsch MJ; Knüsli C
    Klin Wochenschr; 1982 Nov; 60(21):1339-49. PubMed ID: 7154614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analgesic nephropathy in the 1990s--an Australian perspective.
    Nanra RS
    Kidney Int Suppl; 1993 Jul; 42():S86-92. PubMed ID: 8361137
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.